In Search of an Ideal Biomarker for Nonalcoholic Fatty Liver Disease.

The article presents the authors' comments on whether an ideal biomarker exists for the progression of nonalcoholic fatty liver disease (NAFLD) in humans. They state that an ideal biomarker should have the characteristics including, it should be minimally invasive, it should allow repetitive measurements and should be able to identify early stages of the disease. They suggest that biomarkers for NAFLD require a combination of advanced techniques like genomics with polymorphism.